期刊文献+

肌氨酸的检测方法及其临床应用进展

Progress in Detection Methods and Clinical Application of Sarcosine
下载PDF
导出
摘要 目前肌氨酸的检测方法有多种,包括酶法、色谱法、质谱法、光谱法、电化学法、生物传感器法、比色法等,但各种方法特异性不尽相同。临床上不同方法的检测结果存在一定差异,全面系统地比较这些差异性有助于肌氨酸在临床的进一步应用。当前肌氨酸作为诊断和预测前列腺癌(PCa)的指标具有很高的灵敏度和特异度,尤其是与其他生物标志物联合诊断时,在准确性和高效性等方面具有显著优势。因此,未来寻找一种更准确、更快速的检测方法对PCa早期诊断至关重要。 At present,there are various detection methods of sarcosine,including enzymatic assays,chromatography,mass spectrometry,spectroscopy,electrochemical method,biosensor method,colorimetric method etc.,but the specificity of each method is not the same.There are some differences in the results of different clinical methods.A comprehensive and systematic comparison of these differences will help to further apply sarcosine in clinical practice.At present,sarcosine has good specificity and sensitivity as an indicator for the diagnosis and prediction of prostate cancer(PCa),which especially has significant advantages in accuracy and efficiency when combined with other biomarkers.Therefore,the search for a more accurate and rapid detection method will be crucial in the early diagnosis of PCa in the future.
作者 唐耿秋 苏雨琳 陈树煌 卢昌华 陈桂滨 TANG Gengqiu;SU Yulin;CHEN Shuhuang;LU Changhua;CHEN Guibin(Guangdong Chaozhou Health Vocational College,Chaozhou 521000,China)
出处 《医学综述》 CAS 2024年第18期2281-2287,共7页 Medical Recapitulate
基金 广东省普通高校青年创新人才项目(2020KQNCX255)。
关键词 肌氨酸 检测方法 前列腺癌 Sarcosine Detection methods Prostate cancer
  • 相关文献

参考文献16

二级参考文献134

  • 12004年上海市市区恶性肿瘤发病率[J].肿瘤,2007,27(7):594-594. 被引量:23
  • 2Jemal A,Siegel R,Ward R,et al.Cancer statistics,2008[J].CA Cancer J Clin,2008,58(2):71-96.
  • 3Zhao Z,Shen W.Prostate stem cell antigen (PSCA) expression in human prostate cancer tissues and its potential role in prostate carcinogenesis and progression of prostate cancer[J/OL].World J Surg Oncol,2004[2010-05-13].http://www.ncbi.nlm.nih.gov/pubmed/15132743.
  • 4Cavaliere B,Macchione B,Monteleone M,et al.Sarcosine as a marker in prostate cancer progression:a rapid and simple method for its quantification in human urine by solid-phase microextraction-gas chromatography-triple quadrupole mass spectrometry[J].Anal Bioanal Chem,2011,400(9):2903-2912.
  • 5Tomlins SA,Rhodes DR,Perner S,et al.Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer[J].Science,2005,310(5748):644-648.
  • 6Kumar-Sinha C,Tomlins SA,Chinnaiyan AM.Recurrent gene fusions in prostate cancer[J].Nat Rev Cancer,2008,8(7):497-511.
  • 7Narod SA,Seth A,Nam R.Fusion in the ETS gene family and prostate cancer[J].Br J Cancer,2008,99(6):847-851.
  • 8Clark J,Merson S,Jhavar S,et al.Diversity of TMPRSS2-ERG fusion transcripts in the human prostate[J].Oncogene,2007,26(18):2667-2673.
  • 9Jentzmik F,Stephan C,Miller K,et al.Sarcosine in urine after digital rectal examination fails as a marker in prostate cancer detection and identification of aggressive tumors[J].Eur Urol,2010,58(1):12-18.
  • 10Jentzmik F,Stephan C,Lein M,et al.Sarcosine in prostate cancer tissue is not a differential metabolite for prostate cancer aggressiveness and biochemical progression[J].J Urol,2011,185(2):706-711.

共引文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部